Register Now: Does Your Pharmaceutical WMS Grow with You?
News|Articles|February 14, 2025

Pharma Pulse 2/14/25: RFK Jr. Confirmed as HHS Secretary, How Pharma Can Effectively Combat Misinformation & more

The latest news for pharma industry insiders.

How Pharma Can Effectively Combat Misinformation/Disinformation

In this part of his Pharmaceutical Executive video interview, Ian Baer, Founder & CEO of Sooth, identifies strategies pharmaceutical companies can use to combat misinformation on social media.

Partnering for Women’s Health: The Pharmacist’s Collaborative Role

Panelists discuss how health care professionals collaborate through interdisciplinary teams, integrated care coordination, and lifecycle-specific approaches to provide comprehensive women’s health care, addressing gaps by implementing patient-centered, culturally sensitive models that prioritize holistic well-being across different life stages.

Robert F. Kennedy Jr. Confirmed as HHS Secretary

Kennedy was confirmed by a mostly party-line vote in the Senate.

Angels for Change Launches Project GOLD

Angels for Change (A4C) announces the pilot launch of Project GOLD (Generic Oncology Lifesaving Drugs), a new resiliency program that establishes an onshore buffer supply of six essential medications that are used to treat cancer. Project GOLD was created to offer physicians and patients stability of care during a shortage through emergency supply at leading distributors and manufacturers. A4C is participating with founding pilot members, pharmaceutical wholesalers Cencora and McKesson, and pharmaceutical and medtech manufacturer Fresenius Kabi, highlighting the power of collaboration in addressing this critical issue.

Joel Wayment on LinkedIn

In this month’s edition of Pharmaceutical Commerce Magazine, I share my insights on factors to consider when choosing a 3PL, industry trends to keep an eye on and more.

Check out the article to learn more: https://lnkd.in/eKHCVBYx

#3PL #Sustainability #Biopharma

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs


Related to this article

CVS Pharmacy Sign at Storefront Entrance | © Mark Roger Bailey - stock.adobe.com 557616813
In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean for its launch strategies and an ACTO survey finds most life sciences leaders see no clear industry standard for responsible AI.